Showing results (1531-1540 of 2,304) with videos related to
Sort By:
Pageof 231
Thrombosis and Haemostasis|February 6, 2010
Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndromeThomas Cuisset, Michalis Hamilos, Michalis Delrue, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot studyRajiv Saran, James E Novak, Anjali Desai, et al.Targeted Oncology|March 17, 2011
Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancerPaola Claudia Sacco, Paolo Maione, Antonio Rossi, et al.International Journal of Cardiology|January 14, 2020
Coronary microcirculation and peri-procedural myocardial injury during elective percutaneous coronary interventionFabio Mangiacapra, Edoardo Bressi, Giuseppe Di Gioia, et al.Journal of Cardiovascular Translational Research|October 22, 2013
Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR TrialEmanuele Barbato, Arnold Herman, Edouard Benit, et al.Redox Biology|November 16, 2020
The Nrf2 induction prevents ferroptosis in Friedreich's AtaxiaPiergiorgio La Rosa, Sara Petrillo, Riccardo Turchi, et al.Current Neuropharmacology|October 15, 2024
Reduced Serum Brain-Derived Neurotrophic Factor in Infants Affected by Severe BronchiolitisRaffaella Nenna, Carla Petrella, Enea Bonci, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 10, 2020
The impact of the extent of side branch disease on outcomes following bifurcation stentingMarco Zimarino, Emanuele Barbato, Sunao Nakamura, et al.Multiple Sclerosis and Related Disorders|August 13, 2015
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisEdward Fox, Keith Edwards, Gordon Burch, et al.Multiple Sclerosis and Related Disorders|August 13, 2015
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisBruce Hughes, Mark Cascione, Mark S Freedman, et al.Pageof 231